KR860000065A - 국부적이고 계통적인 약물의 경피 및 전위막 침투를 증강시키는 조성물 및 방법 - Google Patents
국부적이고 계통적인 약물의 경피 및 전위막 침투를 증강시키는 조성물 및 방법 Download PDFInfo
- Publication number
- KR860000065A KR860000065A KR1019850004121A KR850004121A KR860000065A KR 860000065 A KR860000065 A KR 860000065A KR 1019850004121 A KR1019850004121 A KR 1019850004121A KR 850004121 A KR850004121 A KR 850004121A KR 860000065 A KR860000065 A KR 860000065A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- active substance
- compound
- carbon atoms
- alkyl group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (16)
- m이 4 내지 9이고; R1이 수소이거나 1 내지 8개의 탄소원자를 갖는 알킬그룹이고; R은 1 내지 20개의 탄소원자를 갖는 직쇄 또는 측쇄 알킬그룹인 구조식,을 갖는 화합물의 비독성 침투량과 약리학적 활성물질의 효과적인 양으로 구성되는 약리학적 활성물질의 경피 및 전위막 침투를 증강시키는 극소적 조성물.
- 활성물질이 항생제인 청구범위 제1항의 조성물.
- m이 4 내지 6이고, R1이 수소이고, R이 1 내지 20인 청구범위 제2항의 화합물.
- m이 6이고, R1이 수소이고, R은 운데실이며, 그 화합물이 헥사메틸렌라우르 아미드인 청구범위 제3항의 조성물.
- 항생물질이 에리트로마이신 및 린크 마이신으로 구성되는 그룹으로부터 선택되는 청구범위 제2항의 조성물.
- 활성물질이 항진균제인 청구범위 제1항의 조성물.
- 활성물질이 스테로이드인 청구범위 제1항의 조성물.
- m이 4 내지 9이고; R1이 수소이거나 1 내지 8개의 탄소원자를 갖는 알킬그룹이며; R은 1 내지 20개의 탄소원자를 갖는 직쇄 또는 측쇄 알킬그룹인 구조식,을 갖는 화합물의 침투량과 약리학적 활성물질의 유효량으로 구성되는 조성물을 인간이나 동물에 극부적으로 투여하는 것으로 구성되는 약리학적 활성물질의 경피 및 전위막 침투를 증강시키는 방법.
- 활성물질의 항생제인 청구범위 제8항의 방법.
- 활성물질의 항진균제인 청구범위 제8항의 방법.
- 활성물질이 스테로이드인 청구범위 제8항의 방법.
- m이 6이고, R1이 운데실이며, 그 화합물이 헥사메틸렌라우르 아미드인 청구범위 제8항의 방법.
- m이 4 내지 9이고, R1이 수소이거나, 1 내지 8개의 탄소원자를 갖는 알킬그룹이고, R은 1 내지 20개의 탄소원자를 갖는 직쇄 또는 측쇄알킬 그룹인 구조식,을 갖는 화합물의 비독성 침투량을 비독성 제약상 담체와 혼합하는 것으로 구성되는 약리학적 활성물질의 경피 및 전위막 침투를 증강시키는 극소적 조성물을 제조하는 방법.
- 상기 조성물이 용액인 청구범위 제13항의 방법.
- 상기 조성물이 크림인 청구범위 제13항의 방법.
- 상기 조성물이 연고인 청구범위 제13항의 방법.※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/620,229 US4743588A (en) | 1984-06-13 | 1984-06-13 | Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents |
US620229 | 1996-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR860000065A true KR860000065A (ko) | 1986-01-25 |
Family
ID=24485099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850004121A KR860000065A (ko) | 1984-06-13 | 1985-06-12 | 국부적이고 계통적인 약물의 경피 및 전위막 침투를 증강시키는 조성물 및 방법 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4743588A (ko) |
EP (1) | EP0164998A3 (ko) |
JP (1) | JPS611623A (ko) |
KR (1) | KR860000065A (ko) |
AU (1) | AU582364B2 (ko) |
CA (1) | CA1255594A (ko) |
DK (1) | DK259485A (ko) |
EG (1) | EG17345A (ko) |
FI (1) | FI852331L (ko) |
GR (1) | GR851421B (ko) |
HU (1) | HU193774B (ko) |
IL (1) | IL75488A (ko) |
NZ (1) | NZ212368A (ko) |
PT (1) | PT80625B (ko) |
ZA (1) | ZA854365B (ko) |
ZW (1) | ZW9985A1 (ko) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
WO1987004594A1 (en) * | 1986-01-31 | 1987-08-13 | Nelson Research And Development Company | Compositions comprising 1-substituted azacycloalkanes and their uses |
CA1298557C (en) * | 1986-01-31 | 1992-04-07 | Whitby Research Incorporated | Compositions comprising 1-substituted azacyclo-alkanes |
US5204339A (en) * | 1986-01-31 | 1993-04-20 | Whitby Research, Inc. | Penetration enhancers for transdermal delivery of systemic agents |
EP0247900B1 (en) * | 1986-05-30 | 1991-12-18 | The Regents Of The University Of California | Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease |
CA1308352C (en) * | 1986-08-15 | 1992-10-06 | James V. Peck | Compositions comprising 1-oxohydrocarbyl-substituted azacyclohexanes |
US4917896A (en) * | 1986-08-15 | 1990-04-17 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agents |
US4808414A (en) * | 1986-09-29 | 1989-02-28 | Nelson Research & Development Co. | Amide penetration enhancers for transdermal delivery of systemic agents |
DE3778833D1 (de) * | 1986-11-19 | 1992-06-11 | Whitby Research Inc | Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln. |
EP0268219A1 (en) * | 1986-11-19 | 1988-05-25 | Whitby Research Incorporated | Penetration enhancers for transdermal delivery of systemic agents |
US5112804A (en) * | 1987-04-01 | 1992-05-12 | Temple University Of The Commonwealth System Of Higher Education | Pharmaceutical composition and method of intranasal administration |
US4879275A (en) * | 1987-09-30 | 1989-11-07 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agent |
US4920101A (en) * | 1987-09-30 | 1990-04-24 | Nelson Research & Development Co. | Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes |
CA1334646C (en) * | 1988-04-08 | 1995-03-07 | James Vanolden Peck | Transdermal penetration enhancers |
EP0425505B1 (en) * | 1988-06-30 | 1993-03-17 | The Upjohn Company | Transdermal antisecretory agents for gastrointestinal disease |
US5059603A (en) * | 1989-06-12 | 1991-10-22 | Centuries Laboratories, Inc. | Method and composition for treating impotence |
US5981591A (en) * | 1992-12-04 | 1999-11-09 | Mayor Pharmaceutical Laboratories, Inc. | Sprayable analgesic composition and method of use |
US6767925B1 (en) | 1996-10-31 | 2004-07-27 | Joseph A. Deihl | Sprayable analgesic composition and method of use |
US6797276B1 (en) * | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
IL136042A (en) | 1997-11-10 | 2005-12-18 | Cellegy Pharma Inc | Alcohol-containing composition for topical application |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
US6262117B1 (en) | 1999-02-18 | 2001-07-17 | Allergan Sales, Inc. | Method and composition for treating acne |
JP4932086B2 (ja) * | 1999-04-08 | 2012-05-16 | インターセル ユーエスエイ、インコーポレイテッド | 経皮的免疫のための乾燥製剤 |
AU2002250071B2 (en) * | 2001-02-13 | 2008-02-14 | Government Of The United States, As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
US6521613B2 (en) | 2001-04-10 | 2003-02-18 | Allergan, Inc. | Lactam compounds for penetration enhancement |
US20030175329A1 (en) * | 2001-10-04 | 2003-09-18 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
US20060222692A1 (en) * | 2005-03-31 | 2006-10-05 | Fairfield Clinical Trials Llc | Method and compositions for transdermal administration of antimicrobial medications |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3223708A (en) * | 1962-05-24 | 1965-12-14 | Robert R Mod | N-decanoyltetrahydroquinoline |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
DE3009546A1 (de) * | 1980-03-13 | 1981-09-24 | Henkel KGaA, 4000 Düsseldorf | Desodorierende kosmetische zusammensetzungen |
-
1984
- 1984-06-13 US US06/620,229 patent/US4743588A/en not_active Expired - Lifetime
-
1985
- 1985-06-04 EP EP85303933A patent/EP0164998A3/en not_active Withdrawn
- 1985-06-10 JP JP60125944A patent/JPS611623A/ja active Pending
- 1985-06-10 DK DK259485A patent/DK259485A/da not_active Application Discontinuation
- 1985-06-10 ZA ZA854365A patent/ZA854365B/xx unknown
- 1985-06-10 ZW ZW99/85A patent/ZW9985A1/xx unknown
- 1985-06-11 GR GR851421A patent/GR851421B/el unknown
- 1985-06-11 PT PT80625A patent/PT80625B/pt unknown
- 1985-06-11 NZ NZ212368A patent/NZ212368A/en unknown
- 1985-06-11 AU AU43452/85A patent/AU582364B2/en not_active Ceased
- 1985-06-12 HU HU852321A patent/HU193774B/hu not_active IP Right Cessation
- 1985-06-12 FI FI852331A patent/FI852331L/fi not_active Application Discontinuation
- 1985-06-12 CA CA000483807A patent/CA1255594A/en not_active Expired
- 1985-06-12 IL IL75488A patent/IL75488A/xx unknown
- 1985-06-12 KR KR1019850004121A patent/KR860000065A/ko not_active Application Discontinuation
- 1985-06-13 EG EG358/85A patent/EG17345A/xx active
Also Published As
Publication number | Publication date |
---|---|
ZA854365B (en) | 1986-05-28 |
US4743588A (en) | 1988-05-10 |
JPS611623A (ja) | 1986-01-07 |
EG17345A (en) | 1991-03-30 |
GR851421B (ko) | 1985-11-25 |
AU4345285A (en) | 1985-12-19 |
FI852331L (fi) | 1985-12-14 |
HU193774B (en) | 1987-11-30 |
PT80625B (en) | 1987-03-26 |
EP0164998A3 (en) | 1987-06-16 |
FI852331A0 (fi) | 1985-06-12 |
IL75488A (en) | 1989-07-31 |
DK259485D0 (da) | 1985-06-10 |
PT80625A (en) | 1985-07-01 |
DK259485A (da) | 1985-12-14 |
CA1255594A (en) | 1989-06-13 |
ZW9985A1 (en) | 1985-09-04 |
EP0164998A2 (en) | 1985-12-18 |
AU582364B2 (en) | 1989-03-23 |
HUT38543A (en) | 1986-06-30 |
NZ212368A (en) | 1988-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR860000065A (ko) | 국부적이고 계통적인 약물의 경피 및 전위막 침투를 증강시키는 조성물 및 방법 | |
KR920700601A (ko) | 피부투과 증진제 조성물 | |
KR890011585A (ko) | 경피식 피임약제제형 | |
KR880000093A (ko) | 신규의 국소처리용 약제학적 조성물 | |
KR890015745A (ko) | 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법 | |
KR890015732A (ko) | 소염성 겔 | |
KR860003830A (ko) | 가용화한 백금화합물 및 그 제조방법 | |
KR850002377A (ko) | 살충제 조성물 | |
KR970061246A (ko) | 테스토스테론을 증가시키기 위한 약학 조성물 | |
KR890011602A (ko) | 안과용 조성물과 그 제조방법 | |
KR910007509A (ko) | 친유성 약제용 주사 조성물 | |
KR890014480A (ko) | 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
KR870005968A (ko) | 아미드 유도체 및 이를 함유하는 외용약제 | |
KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
KR900007415A (ko) | 기억장해 개선약 | |
KR890003793A (ko) | 3'-데메톡시에피포도필로톡신 배당체의 유도체 | |
KR900003174A (ko) | 벤조푸로[3,2-c] 퀴놀린 화합물 | |
KR850005227A (ko) | 농원예용 살균제 조성물 | |
KR840008329A (ko) | 2-에틸-4-메틸이미다졸의 결정화 방지방법 | |
Tusing et al. | The chronic dermal toxicity of a series of polyethylene glycols | |
KR890003762A (ko) | 10.11-디하이드로-5H- 디벤조[a,d]사이클로헵텐-5,10-이민의 폴리하이드로 유도체 | |
KR890001432A (ko) | 흡혈 곤충으로 인한 피해의 방지 방법 | |
KR850007582A (ko) | 모노아실 폴리알킬렌 폴리아민의 제조방법 | |
KR880003623A (ko) | 시알로실글리세로리피드로 된 신경장해질환 치료제 | |
KR920000319A (ko) | 암 예방 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |